← Leaderboards
Hans K. Ghayee
University Of Florida
$419,375
Attributed
$419,375
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $228.8K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$419,375 · 1
By mechanism
R21$419,375 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- John M Buatti$4,178,356
- Lauren Fishbein$1,780,967
- Colin Sumners$12,690,977
Others in their field
Other Emerging Leaders on “Anabolism”
- Terry Roemer · Prokaryotics, Inc.$13,565,894
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Zhao Wang · Ut Southwestern Medical Center$5,368,275
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$4,982,483
- Yousong Ding · University Of Florida$4,468,134
- Andrew T Ulijasz · Loyola University Chicago$3,784,401
Research focus
AnabolismAnalogAnimalsBaseBasic ScienceBiochemicalBiochemistryBiological MarkersBiological ModelsBiological ProcessBreast Cancer TreatmentBurden Of IllnessCancer ModelCancer PatientCancer TherapyCatecholaminesCell GrowthCell LineCellsCell SurvivalClinicClinical TrialsCombined Modality TherapyAgreement
Grant awards (2)
Preclinical evaluation of the efficacy and mechanism of action for an alkylated polyamine analogue diethylnorspermine in treating pheochromocytoma/paraganglioma$190,625
R21 · FY2021 · TR · contact PI
Preclinical evaluation of the efficacy and mechanism of action for an alkylated polyamine analogue diethylnorspermine in treating pheochromocytoma/paraganglioma$228,750
R21 · FY2020 · TR · contact PI